WEDNESDAY, SEPTEMBER 2, 2020
Imagine a world without the stigma surrounding abortion. Abortion would be recognized as health care. People would not be deprived of their right to make their own reproductive decisions. Abortion providers would not be isolated or face physical threats on their lives.
A world free of abortion stigma is the vision driving the work of the International Network for the Reduction of Abortion Discrimination and Stigma (inroads), a network and global community of practice that grew out of a 2013 meeting on abortion stigma co-convened by Ipas and Advancing New Standards in Reproductive Health (ANSIRH). Inroads was launched following that meeting, with Ipas serving as its host and providing operational support. Today inroads is a network of scholars, advocates, health providers and donors representing 1,500 members and 105 countries.
Expert: Find solution to curb rise of online abortion pills
The availability of medical abortion as a safe choice for women supervised by medical professionals will in turn decrease the need for women to resort to illegal and unsafe methods.
By Teh Athira Yusof
January 6, 2020
KUALA LUMPUR: Solutions must be provided to overcome the rise in the sale of abortion pills online.
Federation of Reproductive Health Association of Malaysia medical committee member Dr John Teo said prevention, support, destigmatisation of abortion and better access to safe and legal termination of pregnancy would address the online sale of abortion pills effectively.
D.I.Y. – Self-Managed Abortion
Conscience Magazine, 2019 issue 2, Abortion
By Susan Yanow, Joanna Erdman and Kinga Jelinska
Posted Sep 19, 2019
The advent of abortion pills as a health technology has deep personal and political consequences for how, when and where abortions happen. The “discovery” of abortion pills occurred in the 1980s in Brazil, when women noticed that the label for misoprostol, a drug registered to treat gastric ulcers, cautioned against its use by pregnant women because the drug caused uterine cramping. Use of misoprostol alone to end unwanted pregnancy spread quickly in Brazil and across Latin America outside the formal health system, as abortion is criminalized in most of the region. 1
The use of pills for abortion entered formal healthcare systems when the French pharmaceutical company Roussel-Uclaf developed mifepristone for use with a prostaglandin like misoprostol to end a pregnancy (with higher effectiveness than misoprostol alone, although the World Health Organization (WHO) recognizes both misoprostol alone and the combination mifepristone/misoprostol as highly safe and effective).2